5 completed. 4 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Pfenex, Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Comparison of PF708 and Forteo in Osteoporosis Patients Teriparatide (PF708), Teriparatide (Forteo) - Osteoporosis | Phase 3 | Completed | Pfenex, Inc | 181 | 2016-12-01 | 2018-05-23 |
| A Comparison Study of PF708 and Forteo in Healthy Subjects Teriparatide - Osteoporosis | Phase 1 | Completed | Pfenex, Inc | 70 | 2015-12-01 | 2016-08-04 |
| A Study of Anthrax Vaccines Px563L and RPA563 in Healthy Adult Subjects Px563L, RPA563, or placebo - Anthrax | Phase 1 | Completed | Pfenex, Inc | 54 | 2015-12-01 | 2017-07-11 |
| Comparison Study of PF530 and Betaferon in Healthy Subjects Interferon beta-1b (PF530, Betaferon) - Multiple Sclerosis | Phase 1 | Completed | Pfenex, Inc | 12 | 2015-03-01 | 2015-11-16 |
| Safety Study of PF582 Versus Lucentis in Patients With Age Related Macular Degeneration Lucentis, PF582 - Age Related Macular Degeneration (AMD) | Phase 1 / Phase 2 | Completed | Pfenex, Inc | 25 | 2013-11-01 | 2016-05-11 |
Osteoporosis (2) · Anthrax (1) · Macular Degeneration (1) · Multiple Sclerosis (1)
Teriparatide (2) · Interferon beta-1b (1) · Ranibizumab (1)
United States (3) · Australia (1) · New Zealand (1)
Hubert C Chen, MD (3) · Hubert C Chen, M.D. (2) · Barbara K Lomeli, M.D. (1) · Philip Polkinghorne, MD (1) · Sepehr Shakib, MD (1)